these are: LPAC (Low-Phospholipid Associated Cholelithiasis) [17] RIC (Recurrent Intrahepatic Cholestasis) [18] ICP (Intrahepatic Cholestasis of Pregnancy [23] Cofactor of progression in other liver diseases [24] HBC (Hepatobiliary cancer) [9] While in many cases the symptoms of these diseases can be controlled for a long time, in other cases the patient can undergo rapid progression, fibrosis, or cancer [9]
For patients with recurrent urinary tract infections, clinicians can weigh cardiovascular benefits against infection risks based on infection history, urine culture results, and microbial profiles to choose alternative medications or enhance preventive measures
Ingredients used in the prescribed medications are sourced from FDA-regulated suppliers and are compounded in FDA-regulated facilities
Regardless of participants type 2 diabetes status, researchers found that people receiving tirzepatide injections lost about 7% more weight than those receiving semaglutide injections in the first year on the medication
This sounds very similar to creatines story, if you are familiar with that